Cargando…

Forensic Toxicological and Medico-Legal Evaluation in a Case of Incongruous Drug Administration in Terminal Cancer Patients

Background: In most cases, palliative care is prescribed to adults diagnosed with cancer. The definition of the most suitable therapy for an effective sedation in terminal cancer patients still represents one of the most challenging goals in medical practice. Due to their poor health, the correct do...

Descripción completa

Detalles Bibliográficos
Autores principales: Basilicata, Pascale, Giugliano, Pasquale, Vacchiano, Giuseppe, Simonelli, Angela, Guadagni, Rossella, Silvestre, Angela, Pieri, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8704381/
https://www.ncbi.nlm.nih.gov/pubmed/34941790
http://dx.doi.org/10.3390/toxics9120356
_version_ 1784621694075273216
author Basilicata, Pascale
Giugliano, Pasquale
Vacchiano, Giuseppe
Simonelli, Angela
Guadagni, Rossella
Silvestre, Angela
Pieri, Maria
author_facet Basilicata, Pascale
Giugliano, Pasquale
Vacchiano, Giuseppe
Simonelli, Angela
Guadagni, Rossella
Silvestre, Angela
Pieri, Maria
author_sort Basilicata, Pascale
collection PubMed
description Background: In most cases, palliative care is prescribed to adults diagnosed with cancer. The definition of the most suitable therapy for an effective sedation in terminal cancer patients still represents one of the most challenging goals in medical practice. Due to their poor health, the correct dosing of drugs used for deep palliative sedation in terminal cancer patients, often already on polypharmacological therapy, can be extremely complicated, also considering possible drug-to-drug interactions that could lead to an increased risk of overdose and/or incongruous administration with fatal outcomes. The case of a terminal cancer patient is presented, focusing on the “adequacy” of administered therapy. Materials and Methods: A young male, affected by Ewing sarcoma, attending a palliative care at his own home, died soon after midazolam administration. Toxicological and histological analyses were performed on body fluids and organ fragments. Results and Discussion: Morphological reliefs evidenced a neoplastic mass, composed of lobulated tissue with a lardy, pinkish-gray consistency, extending from the pleural surface to the lung parenchyma, also present at the sacrum region (S1–S5), at the anterior mediastinum level, occupying the entire left pleural cavity, and infiltrating the ipsilateral lung. Metastatic lesions diffused to rachis and lumbar structures. The brain presented edema and congestion. Toxicological analyses evidenced blood midazolam concentrations in the range of 0.931–1.690 µg/mL, while morphine was between 0.266 and 0.909 µg/mL. Death was attributed to cardiorespiratory depression because of a synergic action between morphine and midazolam. The pharmacological interaction between midazolam and morphine is discussed considering the clinical situation of the patient. The opportunity to proceed with midazolam administration is discussed starting from guidelines recommendation. Finally, professional liability outlines are highlighted.
format Online
Article
Text
id pubmed-8704381
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-87043812021-12-25 Forensic Toxicological and Medico-Legal Evaluation in a Case of Incongruous Drug Administration in Terminal Cancer Patients Basilicata, Pascale Giugliano, Pasquale Vacchiano, Giuseppe Simonelli, Angela Guadagni, Rossella Silvestre, Angela Pieri, Maria Toxics Case Report Background: In most cases, palliative care is prescribed to adults diagnosed with cancer. The definition of the most suitable therapy for an effective sedation in terminal cancer patients still represents one of the most challenging goals in medical practice. Due to their poor health, the correct dosing of drugs used for deep palliative sedation in terminal cancer patients, often already on polypharmacological therapy, can be extremely complicated, also considering possible drug-to-drug interactions that could lead to an increased risk of overdose and/or incongruous administration with fatal outcomes. The case of a terminal cancer patient is presented, focusing on the “adequacy” of administered therapy. Materials and Methods: A young male, affected by Ewing sarcoma, attending a palliative care at his own home, died soon after midazolam administration. Toxicological and histological analyses were performed on body fluids and organ fragments. Results and Discussion: Morphological reliefs evidenced a neoplastic mass, composed of lobulated tissue with a lardy, pinkish-gray consistency, extending from the pleural surface to the lung parenchyma, also present at the sacrum region (S1–S5), at the anterior mediastinum level, occupying the entire left pleural cavity, and infiltrating the ipsilateral lung. Metastatic lesions diffused to rachis and lumbar structures. The brain presented edema and congestion. Toxicological analyses evidenced blood midazolam concentrations in the range of 0.931–1.690 µg/mL, while morphine was between 0.266 and 0.909 µg/mL. Death was attributed to cardiorespiratory depression because of a synergic action between morphine and midazolam. The pharmacological interaction between midazolam and morphine is discussed considering the clinical situation of the patient. The opportunity to proceed with midazolam administration is discussed starting from guidelines recommendation. Finally, professional liability outlines are highlighted. MDPI 2021-12-16 /pmc/articles/PMC8704381/ /pubmed/34941790 http://dx.doi.org/10.3390/toxics9120356 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Case Report
Basilicata, Pascale
Giugliano, Pasquale
Vacchiano, Giuseppe
Simonelli, Angela
Guadagni, Rossella
Silvestre, Angela
Pieri, Maria
Forensic Toxicological and Medico-Legal Evaluation in a Case of Incongruous Drug Administration in Terminal Cancer Patients
title Forensic Toxicological and Medico-Legal Evaluation in a Case of Incongruous Drug Administration in Terminal Cancer Patients
title_full Forensic Toxicological and Medico-Legal Evaluation in a Case of Incongruous Drug Administration in Terminal Cancer Patients
title_fullStr Forensic Toxicological and Medico-Legal Evaluation in a Case of Incongruous Drug Administration in Terminal Cancer Patients
title_full_unstemmed Forensic Toxicological and Medico-Legal Evaluation in a Case of Incongruous Drug Administration in Terminal Cancer Patients
title_short Forensic Toxicological and Medico-Legal Evaluation in a Case of Incongruous Drug Administration in Terminal Cancer Patients
title_sort forensic toxicological and medico-legal evaluation in a case of incongruous drug administration in terminal cancer patients
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8704381/
https://www.ncbi.nlm.nih.gov/pubmed/34941790
http://dx.doi.org/10.3390/toxics9120356
work_keys_str_mv AT basilicatapascale forensictoxicologicalandmedicolegalevaluationinacaseofincongruousdrugadministrationinterminalcancerpatients
AT giuglianopasquale forensictoxicologicalandmedicolegalevaluationinacaseofincongruousdrugadministrationinterminalcancerpatients
AT vacchianogiuseppe forensictoxicologicalandmedicolegalevaluationinacaseofincongruousdrugadministrationinterminalcancerpatients
AT simonelliangela forensictoxicologicalandmedicolegalevaluationinacaseofincongruousdrugadministrationinterminalcancerpatients
AT guadagnirossella forensictoxicologicalandmedicolegalevaluationinacaseofincongruousdrugadministrationinterminalcancerpatients
AT silvestreangela forensictoxicologicalandmedicolegalevaluationinacaseofincongruousdrugadministrationinterminalcancerpatients
AT pierimaria forensictoxicologicalandmedicolegalevaluationinacaseofincongruousdrugadministrationinterminalcancerpatients